California Public Employees Retirement System’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.33M | Buy |
134,637
+7,931
| +6% | +$137K | ﹤0.01% | 1094 |
|
2025
Q1 | $2.77M | Buy |
126,706
+47
| +0% | +$1.03K | ﹤0.01% | 1094 |
|
2024
Q4 | $4.04M | Sell |
126,659
-10,935
| -8% | -$349K | ﹤0.01% | 1090 |
|
2024
Q3 | $3.97M | Sell |
137,594
-35,980
| -21% | -$1.04M | ﹤0.01% | 1104 |
|
2024
Q2 | $6.66M | Buy |
173,574
+27,741
| +19% | +$1.06M | ﹤0.01% | 987 |
|
2024
Q1 | $8.57M | Hold |
145,833
| – | – | 0.01% | 944 |
|
2023
Q4 | $8.73M | Sell |
145,833
-38,011
| -21% | -$2.28M | 0.01% | 921 |
|
2023
Q3 | $6.99M | Buy |
183,844
+1,656
| +0.9% | +$63K | 0.01% | 975 |
|
2023
Q2 | $16.6M | Buy |
182,188
+40,182
| +28% | +$3.66M | 0.01% | 666 |
|
2023
Q1 | $9.37M | Sell |
142,006
-49,958
| -26% | -$3.3M | 0.01% | 879 |
|
2022
Q4 | $9.93M | Buy |
191,964
+22,282
| +13% | +$1.15M | 0.01% | 905 |
|
2022
Q3 | $11.6M | Buy |
+169,682
| New | +$11.6M | 0.01% | 797 |
|
2021
Q2 | – | Sell |
-122,358
| Closed | -$5.25M | – | 1626 |
|
2021
Q1 | $5.25M | Sell |
122,358
-17,620
| -13% | -$756K | ﹤0.01% | 1397 |
|
2020
Q4 | $8.01M | Buy |
139,978
+3,644
| +3% | +$208K | 0.01% | 1152 |
|
2020
Q3 | $4.11M | Buy |
136,334
+3,500
| +3% | +$106K | ﹤0.01% | 1368 |
|
2020
Q2 | $4.34M | Buy |
132,834
+5,622
| +4% | +$184K | ﹤0.01% | 1280 |
|
2020
Q1 | $3.41M | Buy |
127,212
+17,313
| +16% | +$464K | ﹤0.01% | 1261 |
|
2019
Q4 | $3.37M | Buy |
109,899
+20,354
| +23% | +$623K | ﹤0.01% | 1721 |
|
2019
Q3 | $2.16M | Buy |
89,545
+45,670
| +104% | +$1.1M | ﹤0.01% | 1838 |
|
2019
Q2 | $1.11M | Buy |
43,875
+6,738
| +18% | +$171K | ﹤0.01% | 2094 |
|
2019
Q1 | $724K | Hold |
37,137
| – | – | ﹤0.01% | 2401 |
|
2018
Q4 | $490K | Sell |
37,137
-1,500
| -4% | -$19.8K | ﹤0.01% | 2555 |
|
2018
Q3 | $687K | Sell |
38,637
-8,279
| -18% | -$147K | ﹤0.01% | 2528 |
|
2018
Q2 | $1.03M | Buy |
+46,916
| New | +$1.03M | ﹤0.01% | 2311 |
|